0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Wound Hemostatic Powder Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-2C14451
Home | Market Reports | Health| Medical Devices & Equipment
Global Wound Hemostatic Powder Market Research Report 2023
BUY CHAPTERS

Global Wound Hemostatic Powder Market Research Report 2025

Code: QYRE-Auto-2C14451
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Wound Hemostatic Powder Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Wound Hemostatic Powder Market

Wound Hemostatic Powder Market

The global market for Wound Hemostatic Powder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Wound Hemostatic Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wound Hemostatic Powder.
The Wound Hemostatic Powder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Wound Hemostatic Powder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wound Hemostatic Powder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Wound Hemostatic Powder Market Report

Report Metric Details
Report Name Wound Hemostatic Powder Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Surgery Center
  • Household
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, BD, Johnson & Johnson, MedTrade Products, C. R. Bard, Equimedical, MBP, Celox, Ferrosan Medical Devices, Betatech Medical, BioCer Entwicklungs, Hemostasis, Aegis Lifesciences, CSL Behring, Gelita Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Wound Hemostatic Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Wound Hemostatic Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Wound Hemostatic Powder Market report?

Ans: The main players in the Wound Hemostatic Powder Market are Pfizer, BD, Johnson & Johnson, MedTrade Products, C. R. Bard, Equimedical, MBP, Celox, Ferrosan Medical Devices, Betatech Medical, BioCer Entwicklungs, Hemostasis, Aegis Lifesciences, CSL Behring, Gelita Medical

What are the Application segmentation covered in the Wound Hemostatic Powder Market report?

Ans: The Applications covered in the Wound Hemostatic Powder Market report are Hospital, Clinic, Surgery Center, Household, Others

What are the Type segmentation covered in the Wound Hemostatic Powder Market report?

Ans: The Types covered in the Wound Hemostatic Powder Market report are Plant Hemostatic Powder, Gelatin Hemostatic Powder, Others

Recommended Reports

Hemostatic Products

Hemostasis & Coagulation

Wound & Surgical Care

1 Wound Hemostatic Powder Market Overview
1.1 Product Definition
1.2 Wound Hemostatic Powder by Type
1.2.1 Global Wound Hemostatic Powder Market Value Comparison by Type (2024 VS 2031)
1.2.2 Plant Hemostatic Powder
1.2.3 Gelatin Hemostatic Powder
1.2.4 Others
1.3 Wound Hemostatic Powder by Application
1.3.1 Global Wound Hemostatic Powder Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Surgery Center
1.3.5 Household
1.3.6 Others
1.4 Global Wound Hemostatic Powder Market Size Estimates and Forecasts
1.4.1 Global Wound Hemostatic Powder Revenue 2020-2031
1.4.2 Global Wound Hemostatic Powder Sales 2020-2031
1.4.3 Global Wound Hemostatic Powder Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Wound Hemostatic Powder Market Competition by Manufacturers
2.1 Global Wound Hemostatic Powder Sales Market Share by Manufacturers (2020-2025)
2.2 Global Wound Hemostatic Powder Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Wound Hemostatic Powder Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Wound Hemostatic Powder, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Wound Hemostatic Powder, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wound Hemostatic Powder, Product Type & Application
2.7 Global Key Manufacturers of Wound Hemostatic Powder, Date of Enter into This Industry
2.8 Global Wound Hemostatic Powder Market Competitive Situation and Trends
2.8.1 Global Wound Hemostatic Powder Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Wound Hemostatic Powder Players Market Share by Revenue
2.8.3 Global Wound Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Wound Hemostatic Powder Market Scenario by Region
3.1 Global Wound Hemostatic Powder Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Wound Hemostatic Powder Sales by Region: 2020-2031
3.2.1 Global Wound Hemostatic Powder Sales by Region: 2020-2025
3.2.2 Global Wound Hemostatic Powder Sales by Region: 2026-2031
3.3 Global Wound Hemostatic Powder Revenue by Region: 2020-2031
3.3.1 Global Wound Hemostatic Powder Revenue by Region: 2020-2025
3.3.2 Global Wound Hemostatic Powder Revenue by Region: 2026-2031
3.4 North America Wound Hemostatic Powder Market Facts & Figures by Country
3.4.1 North America Wound Hemostatic Powder Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Wound Hemostatic Powder Sales by Country (2020-2031)
3.4.3 North America Wound Hemostatic Powder Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Wound Hemostatic Powder Market Facts & Figures by Country
3.5.1 Europe Wound Hemostatic Powder Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Wound Hemostatic Powder Sales by Country (2020-2031)
3.5.3 Europe Wound Hemostatic Powder Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wound Hemostatic Powder Market Facts & Figures by Region
3.6.1 Asia Pacific Wound Hemostatic Powder Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Wound Hemostatic Powder Sales by Region (2020-2031)
3.6.3 Asia Pacific Wound Hemostatic Powder Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Wound Hemostatic Powder Market Facts & Figures by Country
3.7.1 Latin America Wound Hemostatic Powder Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Wound Hemostatic Powder Sales by Country (2020-2031)
3.7.3 Latin America Wound Hemostatic Powder Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wound Hemostatic Powder Market Facts & Figures by Country
3.8.1 Middle East and Africa Wound Hemostatic Powder Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Wound Hemostatic Powder Sales by Country (2020-2031)
3.8.3 Middle East and Africa Wound Hemostatic Powder Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Wound Hemostatic Powder Sales by Type (2020-2031)
4.1.1 Global Wound Hemostatic Powder Sales by Type (2020-2025)
4.1.2 Global Wound Hemostatic Powder Sales by Type (2026-2031)
4.1.3 Global Wound Hemostatic Powder Sales Market Share by Type (2020-2031)
4.2 Global Wound Hemostatic Powder Revenue by Type (2020-2031)
4.2.1 Global Wound Hemostatic Powder Revenue by Type (2020-2025)
4.2.2 Global Wound Hemostatic Powder Revenue by Type (2026-2031)
4.2.3 Global Wound Hemostatic Powder Revenue Market Share by Type (2020-2031)
4.3 Global Wound Hemostatic Powder Price by Type (2020-2031)
5 Segment by Application
5.1 Global Wound Hemostatic Powder Sales by Application (2020-2031)
5.1.1 Global Wound Hemostatic Powder Sales by Application (2020-2025)
5.1.2 Global Wound Hemostatic Powder Sales by Application (2026-2031)
5.1.3 Global Wound Hemostatic Powder Sales Market Share by Application (2020-2031)
5.2 Global Wound Hemostatic Powder Revenue by Application (2020-2031)
5.2.1 Global Wound Hemostatic Powder Revenue by Application (2020-2025)
5.2.2 Global Wound Hemostatic Powder Revenue by Application (2026-2031)
5.2.3 Global Wound Hemostatic Powder Revenue Market Share by Application (2020-2031)
5.3 Global Wound Hemostatic Powder Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Wound Hemostatic Powder Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 BD
6.2.1 BD Company Information
6.2.2 BD Description and Business Overview
6.2.3 BD Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BD Wound Hemostatic Powder Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Wound Hemostatic Powder Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 MedTrade Products
6.4.1 MedTrade Products Company Information
6.4.2 MedTrade Products Description and Business Overview
6.4.3 MedTrade Products Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MedTrade Products Wound Hemostatic Powder Product Portfolio
6.4.5 MedTrade Products Recent Developments/Updates
6.5 C. R. Bard
6.5.1 C. R. Bard Company Information
6.5.2 C. R. Bard Description and Business Overview
6.5.3 C. R. Bard Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.5.4 C. R. Bard Wound Hemostatic Powder Product Portfolio
6.5.5 C. R. Bard Recent Developments/Updates
6.6 Equimedical
6.6.1 Equimedical Company Information
6.6.2 Equimedical Description and Business Overview
6.6.3 Equimedical Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Equimedical Wound Hemostatic Powder Product Portfolio
6.6.5 Equimedical Recent Developments/Updates
6.7 MBP
6.7.1 MBP Company Information
6.7.2 MBP Description and Business Overview
6.7.3 MBP Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.7.4 MBP Wound Hemostatic Powder Product Portfolio
6.7.5 MBP Recent Developments/Updates
6.8 Celox
6.8.1 Celox Company Information
6.8.2 Celox Description and Business Overview
6.8.3 Celox Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Celox Wound Hemostatic Powder Product Portfolio
6.8.5 Celox Recent Developments/Updates
6.9 Ferrosan Medical Devices
6.9.1 Ferrosan Medical Devices Company Information
6.9.2 Ferrosan Medical Devices Description and Business Overview
6.9.3 Ferrosan Medical Devices Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Ferrosan Medical Devices Wound Hemostatic Powder Product Portfolio
6.9.5 Ferrosan Medical Devices Recent Developments/Updates
6.10 Betatech Medical
6.10.1 Betatech Medical Company Information
6.10.2 Betatech Medical Description and Business Overview
6.10.3 Betatech Medical Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Betatech Medical Wound Hemostatic Powder Product Portfolio
6.10.5 Betatech Medical Recent Developments/Updates
6.11 BioCer Entwicklungs
6.11.1 BioCer Entwicklungs Company Information
6.11.2 BioCer Entwicklungs Description and Business Overview
6.11.3 BioCer Entwicklungs Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BioCer Entwicklungs Wound Hemostatic Powder Product Portfolio
6.11.5 BioCer Entwicklungs Recent Developments/Updates
6.12 Hemostasis
6.12.1 Hemostasis Company Information
6.12.2 Hemostasis Description and Business Overview
6.12.3 Hemostasis Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hemostasis Wound Hemostatic Powder Product Portfolio
6.12.5 Hemostasis Recent Developments/Updates
6.13 Aegis Lifesciences
6.13.1 Aegis Lifesciences Company Information
6.13.2 Aegis Lifesciences Description and Business Overview
6.13.3 Aegis Lifesciences Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aegis Lifesciences Wound Hemostatic Powder Product Portfolio
6.13.5 Aegis Lifesciences Recent Developments/Updates
6.14 CSL Behring
6.14.1 CSL Behring Company Information
6.14.2 CSL Behring Description and Business Overview
6.14.3 CSL Behring Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CSL Behring Wound Hemostatic Powder Product Portfolio
6.14.5 CSL Behring Recent Developments/Updates
6.15 Gelita Medical
6.15.1 Gelita Medical Company Information
6.15.2 Gelita Medical Description and Business Overview
6.15.3 Gelita Medical Wound Hemostatic Powder Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Gelita Medical Wound Hemostatic Powder Product Portfolio
6.15.5 Gelita Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wound Hemostatic Powder Industry Chain Analysis
7.2 Wound Hemostatic Powder Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wound Hemostatic Powder Production Mode & Process Analysis
7.4 Wound Hemostatic Powder Sales and Marketing
7.4.1 Wound Hemostatic Powder Sales Channels
7.4.2 Wound Hemostatic Powder Distributors
7.5 Wound Hemostatic Powder Customer Analysis
8 Wound Hemostatic Powder Market Dynamics
8.1 Wound Hemostatic Powder Industry Trends
8.2 Wound Hemostatic Powder Market Drivers
8.3 Wound Hemostatic Powder Market Challenges
8.4 Wound Hemostatic Powder Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Wound Hemostatic Powder Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Wound Hemostatic Powder Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Wound Hemostatic Powder Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Wound Hemostatic Powder Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Wound Hemostatic Powder Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Wound Hemostatic Powder Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Wound Hemostatic Powder Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Wound Hemostatic Powder Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Wound Hemostatic Powder, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Wound Hemostatic Powder, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Wound Hemostatic Powder, Product Type & Application
 Table 12. Global Key Manufacturers of Wound Hemostatic Powder, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Wound Hemostatic Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wound Hemostatic Powder as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Wound Hemostatic Powder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Wound Hemostatic Powder Sales by Region (2020-2025) & (K Units)
 Table 18. Global Wound Hemostatic Powder Sales Market Share by Region (2020-2025)
 Table 19. Global Wound Hemostatic Powder Sales by Region (2026-2031) & (K Units)
 Table 20. Global Wound Hemostatic Powder Sales Market Share by Region (2026-2031)
 Table 21. Global Wound Hemostatic Powder Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Wound Hemostatic Powder Revenue Market Share by Region (2020-2025)
 Table 23. Global Wound Hemostatic Powder Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Wound Hemostatic Powder Revenue Market Share by Region (2026-2031)
 Table 25. North America Wound Hemostatic Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Wound Hemostatic Powder Sales by Country (2020-2025) & (K Units)
 Table 27. North America Wound Hemostatic Powder Sales by Country (2026-2031) & (K Units)
 Table 28. North America Wound Hemostatic Powder Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Wound Hemostatic Powder Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Wound Hemostatic Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Wound Hemostatic Powder Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Wound Hemostatic Powder Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Wound Hemostatic Powder Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Wound Hemostatic Powder Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Wound Hemostatic Powder Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Wound Hemostatic Powder Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Wound Hemostatic Powder Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Wound Hemostatic Powder Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Wound Hemostatic Powder Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Wound Hemostatic Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Wound Hemostatic Powder Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Wound Hemostatic Powder Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Wound Hemostatic Powder Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Wound Hemostatic Powder Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Wound Hemostatic Powder Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Wound Hemostatic Powder Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Wound Hemostatic Powder Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Wound Hemostatic Powder Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Wound Hemostatic Powder Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Wound Hemostatic Powder Sales (K Units) by Type (2020-2025)
 Table 51. Global Wound Hemostatic Powder Sales (K Units) by Type (2026-2031)
 Table 52. Global Wound Hemostatic Powder Sales Market Share by Type (2020-2025)
 Table 53. Global Wound Hemostatic Powder Sales Market Share by Type (2026-2031)
 Table 54. Global Wound Hemostatic Powder Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Wound Hemostatic Powder Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Wound Hemostatic Powder Revenue Market Share by Type (2020-2025)
 Table 57. Global Wound Hemostatic Powder Revenue Market Share by Type (2026-2031)
 Table 58. Global Wound Hemostatic Powder Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Wound Hemostatic Powder Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Wound Hemostatic Powder Sales (K Units) by Application (2020-2025)
 Table 61. Global Wound Hemostatic Powder Sales (K Units) by Application (2026-2031)
 Table 62. Global Wound Hemostatic Powder Sales Market Share by Application (2020-2025)
 Table 63. Global Wound Hemostatic Powder Sales Market Share by Application (2026-2031)
 Table 64. Global Wound Hemostatic Powder Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Wound Hemostatic Powder Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Wound Hemostatic Powder Revenue Market Share by Application (2020-2025)
 Table 67. Global Wound Hemostatic Powder Revenue Market Share by Application (2026-2031)
 Table 68. Global Wound Hemostatic Powder Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Wound Hemostatic Powder Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Wound Hemostatic Powder Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. BD Company Information
 Table 76. BD Description and Business Overview
 Table 77. BD Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BD Wound Hemostatic Powder Product
 Table 79. BD Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Wound Hemostatic Powder Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. MedTrade Products Company Information
 Table 86. MedTrade Products Description and Business Overview
 Table 87. MedTrade Products Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. MedTrade Products Wound Hemostatic Powder Product
 Table 89. MedTrade Products Recent Developments/Updates
 Table 90. C. R. Bard Company Information
 Table 91. C. R. Bard Description and Business Overview
 Table 92. C. R. Bard Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. C. R. Bard Wound Hemostatic Powder Product
 Table 94. C. R. Bard Recent Developments/Updates
 Table 95. Equimedical Company Information
 Table 96. Equimedical Description and Business Overview
 Table 97. Equimedical Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Equimedical Wound Hemostatic Powder Product
 Table 99. Equimedical Recent Developments/Updates
 Table 100. MBP Company Information
 Table 101. MBP Description and Business Overview
 Table 102. MBP Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. MBP Wound Hemostatic Powder Product
 Table 104. MBP Recent Developments/Updates
 Table 105. Celox Company Information
 Table 106. Celox Description and Business Overview
 Table 107. Celox Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Celox Wound Hemostatic Powder Product
 Table 109. Celox Recent Developments/Updates
 Table 110. Ferrosan Medical Devices Company Information
 Table 111. Ferrosan Medical Devices Description and Business Overview
 Table 112. Ferrosan Medical Devices Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Ferrosan Medical Devices Wound Hemostatic Powder Product
 Table 114. Ferrosan Medical Devices Recent Developments/Updates
 Table 115. Betatech Medical Company Information
 Table 116. Betatech Medical Description and Business Overview
 Table 117. Betatech Medical Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Betatech Medical Wound Hemostatic Powder Product
 Table 119. Betatech Medical Recent Developments/Updates
 Table 120. BioCer Entwicklungs Company Information
 Table 121. BioCer Entwicklungs Description and Business Overview
 Table 122. BioCer Entwicklungs Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. BioCer Entwicklungs Wound Hemostatic Powder Product
 Table 124. BioCer Entwicklungs Recent Developments/Updates
 Table 125. Hemostasis Company Information
 Table 126. Hemostasis Description and Business Overview
 Table 127. Hemostasis Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Hemostasis Wound Hemostatic Powder Product
 Table 129. Hemostasis Recent Developments/Updates
 Table 130. Aegis Lifesciences Company Information
 Table 131. Aegis Lifesciences Description and Business Overview
 Table 132. Aegis Lifesciences Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Aegis Lifesciences Wound Hemostatic Powder Product
 Table 134. Aegis Lifesciences Recent Developments/Updates
 Table 135. CSL Behring Company Information
 Table 136. CSL Behring Description and Business Overview
 Table 137. CSL Behring Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. CSL Behring Wound Hemostatic Powder Product
 Table 139. CSL Behring Recent Developments/Updates
 Table 140. Gelita Medical Company Information
 Table 141. Gelita Medical Description and Business Overview
 Table 142. Gelita Medical Wound Hemostatic Powder Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Gelita Medical Wound Hemostatic Powder Product
 Table 144. Gelita Medical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Wound Hemostatic Powder Distributors List
 Table 148. Wound Hemostatic Powder Customers List
 Table 149. Wound Hemostatic Powder Market Trends
 Table 150. Wound Hemostatic Powder Market Drivers
 Table 151. Wound Hemostatic Powder Market Challenges
 Table 152. Wound Hemostatic Powder Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Wound Hemostatic Powder
 Figure 2. Global Wound Hemostatic Powder Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Wound Hemostatic Powder Market Share by Type: 2024 & 2031
 Figure 4. Plant Hemostatic Powder Product Picture
 Figure 5. Gelatin Hemostatic Powder Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Wound Hemostatic Powder Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Wound Hemostatic Powder Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Surgery Center
 Figure 12. Household
 Figure 13. Others
 Figure 14. Global Wound Hemostatic Powder Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Wound Hemostatic Powder Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Wound Hemostatic Powder Sales (2020-2031) & (K Units)
 Figure 17. Global Wound Hemostatic Powder Average Price (US$/Unit) & (2020-2031)
 Figure 18. Wound Hemostatic Powder Report Years Considered
 Figure 19. Wound Hemostatic Powder Sales Share by Manufacturers in 2024
 Figure 20. Global Wound Hemostatic Powder Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Wound Hemostatic Powder Players: Market Share by Revenue in Wound Hemostatic Powder in 2024
 Figure 22. Wound Hemostatic Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Wound Hemostatic Powder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Wound Hemostatic Powder Sales Market Share by Country (2020-2031)
 Figure 25. North America Wound Hemostatic Powder Revenue Market Share by Country (2020-2031)
 Figure 26. United States Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Wound Hemostatic Powder Sales Market Share by Country (2020-2031)
 Figure 29. Europe Wound Hemostatic Powder Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Wound Hemostatic Powder Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Wound Hemostatic Powder Revenue Market Share by Region (2020-2031)
 Figure 37. China Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Wound Hemostatic Powder Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Wound Hemostatic Powder Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Wound Hemostatic Powder Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Wound Hemostatic Powder Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Wound Hemostatic Powder Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Wound Hemostatic Powder by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Wound Hemostatic Powder by Type (2020-2031)
 Figure 56. Global Wound Hemostatic Powder Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Wound Hemostatic Powder by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Wound Hemostatic Powder by Application (2020-2031)
 Figure 59. Global Wound Hemostatic Powder Price (US$/Unit) by Application (2020-2031)
 Figure 60. Wound Hemostatic Powder Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart